Diodes Incorporated — FY2010 Form 10-K
Reporting period: Fiscal year ended December 31, 2010. This is an annual filing, not a standalone fourth-quarter report. Diodes designs, manufactures and sells standard discrete, logic and analog semiconductors. It reports one operating segment and serves consumer electronics, computing, industrial, communications and automotive markets.
Financial performance
| Metric | FY2010 | FY2009 |
|---|---|---|
| Net sales | $612.9 million | $434.4 million |
| Gross profit / margin | $224.9 million / 36.7% | $121.2 million / 27.9% |
| Operating income / margin | $104.9 million / 17.2% | $22.8 million / 5.3% |
| Net income attributable to common stockholders | $76.7 million | $7.5 million |
| Diluted EPS | $1.68 | $0.17 |
| Cash flow from operations | $118.0 million | $65.5 million |
- Sales rose 41.1%, driven by a 34.3% increase in units and a 5.1% increase in average selling prices. Management attributed stronger results to increased demand across regions, improved product mix, higher utilization and manufacturing efficiencies.
- SG&A increased to $88.8 million, but declined to 14.5% of sales from 16.2%. R&D rose to $26.6 million, or 4.3% of sales.
- FY2010 net income included $3.2 million of other income, including a $1.7 million gain on sale of non-core intellectual property and $1.1 million from forgiveness of Chinese government-subsidy debt. The effective tax rate was 18.2%.
- Fourth-quarter 2010 sales were $163.8 million, gross profit $62.6 million and common-stockholder net income $24.0 million; diluted EPS was $0.52. In Q4 2009, the corresponding figures were $130.3 million, $41.8 million, $14.2 million and $0.32.
Cash, liquidity and debt
- Cash and cash equivalents were $270.9 million at year-end, up from $242.0 million. Working capital was $289.4 million, down from $354.3 million; management attributed the decrease mainly to reclassifying the convertible notes as current liabilities.
- Operating cash flow was $118.0 million. Investing activities provided $209.6 million, principally from $296.6 million of proceeds from liquidating auction-rate securities (ARS), offset in part by capital spending. Financing activities used $295.3 million, primarily to repay the UBS “no net cost” loan.
- Convertible notes had $134.3 million principal outstanding, a 2.25% coupon and a 2026 stated maturity. Their holders could require repurchase at par on October 1, 2011; accordingly, the notes were classified as current at year-end, with a $128.3 million net carrying amount. The company had repurchased $95.7 million principal amount since issuance.
- Credit facilities had no outstanding borrowings at year-end; reported available capacity was $46.7 million after usage for guarantees. Management said cash, operating cash generation and available facilities should cover working-capital and capital needs for at least 12 months.
Changes, outlook and risks
- Compared with 2009, the business rebounded strongly: sales increased 41.1%, gross margin expanded 8.8 percentage points and operating income rose to $104.9 million from $22.8 million. Cash from operations increased $52.5 million.
- Management expected continued improvement in 2011 demand and order rates, further production ramps from design wins, and growth from China. It expected facilities to remain near full utilization, except for reduced China utilization in Q1 because of coastal labor shortages and the Chinese New Year. Planned 2011 capital spending was 10%–12% of sales.
- China capacity expansion includes a Chengdu joint venture in which Diodes expected to hold at least 95%. The company committed to contribute at least $47.5 million in the first three years; the project is planned in phases over ten years and may entail further contributions and execution risks.
- Key exposures include semiconductor cyclicality, pricing pressure, order cancellations, inventory obsolescence, customer qualification and manufacturing disruption. International operations add China labor, regulatory, political and currency risks. No customer represented 10% or more of sales, but related-party dealings and supplier dependencies warrant attention: LSC supplied products representing 6.9% of sales, while Keylink-related manufacturing services cost $14.4 million in 2010.
- The U.K. defined-benefit plan was underfunded by $24.9 million. Approximately $254 million of non-U.S. undistributed earnings were considered permanently reinvested; estimated additional U.S. federal and state tax on repatriation was $44 million. The filing reported no pending litigation and management concluded internal control over financial reporting was effective.
Investor verification points
- Confirm that 2011 demand, utilization and planned capital spending developed as management expected, particularly in China.
- Assess the cash or refinancing plan for the October 2011 noteholder put, alongside the company’s liquidity and credit-facility availability.
- Track whether the 2010 margin recovery persists after accounting for product mix, utilization, pricing and manufacturing costs.
- Review inventory and receivables growth, as both rose substantially during 2010, and monitor potential order cancellations or obsolescence.
- Verify Chengdu joint-venture investment milestones, costs and any related support repayment or additional funding obligations.
- Evaluate pension funding needs, tax exposures on foreign earnings, and the terms and governance of related-party transactions.